{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02616",
      "entity_text" : "AC133",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0416" ],
      "CellLine" : [ "cellosaurus:CVCL_0021" ],
      "Cellular_component" : [ "go:GO:0016020" ],
      "Organ" : [ "uberon:UBERON:0016566" ],
      "Species" : [ "taxonomy:10090" ],
      "CellType" : [ "cl:CL:0000034" ]
    }
  },
  "verbose_text" : "The well characterized NCH421k GBM-SC line has been derived from a primary GBM (WHO grade IV) under stem cell culture conditions XREF_BIBR and displays approximately 10-15-fold lower levels of AC133 than CD133-OE U251 glioma cells.",
  "reading_complete" : "2020-08-02T10:07:56Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T10:06:06Z",
  "trigger" : "levels",
  "evidence" : [ "levels of AC133" ],
  "pmc_id" : "4860894",
  "score" : 0
}